Ameritas Investment Company’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-200
Closed -$14K 1694
2019
Q3
$14K Buy
+200
New +$13.7K ﹤0.01% 1047

Ameritas Investment Company's GHDX Position: Q4 2019 in Review

Ameritas Investment Company sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 200 shares — an estimated $14K sold.

Ameritas Investment Company first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $14K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Ameritas Investment Company reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 200 Genomic Health, Inc. shares in Q4 2019, an estimated $14K.
  • Ameritas Investment Company first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
  • Ameritas Investment Company's Genomic Health, Inc. position peaked at $14K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Ameritas Investment Company's 13F filing for Q4 2019, filed 18 Feb 2020.